title: Austerity and evidence base for single use items in ENT.
authors.forename: A
authors.initials: A
authors.lastname: Parmar
authors.forename: M
authors.initials: M
authors.lastname: Clark
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use; D002701:Chloramphenicol / Q000627:therapeutic use; D002710:Chlorhexidine / Q000627:therapeutic use; D003020:Clothing; D017046:Cost Savings; D003907:Dexamethasone / Q000627:therapeutic use; D004338:Drug Combinations; D017598:Efficiency, Organizational; D005601:Framycetin / Q000627:therapeutic use; D006096:Gramicidin / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D006847:Hydrocarbons, Iodinated / Q000627:therapeutic use; D017053:Infection Control; D009355:Neomycin / Q000627:therapeutic use; D016134:Organizational Policy; D010036:Otolaryngology; D013222:State Medicine; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D006847:Hydrocarbons, Iodinated; C070815:Naseptin; C045757:bismuth iodoform paraffin paste; D006096:Gramicidin; D005601:Framycetin; D002701:Chloramphenicol; C023881:Sofradex; D003907:Dexamethasone; D009355:Neomycin; D002710:Chlorhexidine; D001729:Bismuth